Oprelvekin

Oprelvekin (brand name Neumega) is a medication used to reduce the risk of bleeding in people with low platelet counts (thrombocytopenia). It is also used to reduce the need for red blood cell transfusions in people with bone marrow failure. Oprelvekin is a recombinant form of human interleukin-11, a naturally occurring cytokine. It works by stimulating the production of platelets and red blood cells, which can help reduce the risk of bleeding and the need for transfusion.

Oprelvekin, sold under the brand name Neumega, is a medication used to increase platelet count in adults undergoing specific cancer treatment [1, 2]. Here's a closer look at its function and uses:

Function:

• Oprelvekin is a recombinant human interleukin-11 (IL-11) [1, 3]. Interleukins are natural signaling molecules involved in the immune system.
• In the bone marrow, IL-11 stimulates the growth and maturation of megakaryocytes, which are cells that produce platelets [2, 3].
• Platelets are essential for blood clotting and preventing excessive bleeding.

Uses:

• Oprelvekin is primarily used to prevent severe thrombocytopenia (low platelet count) in adults receiving myelosuppressive chemotherapy for non-myeloid malignancies [1, 2].
  • Myelosuppressive chemotherapy refers to medications that suppress bone marrow activity, potentially leading to reduced blood cell production, including platelets.
  • Non-myeloid malignancies are cancers that don't originate in the bone marrow, such as some solid tumors.

How it's Given:

• Oprelvekin is typically administered as a subcutaneous injection (under the skin) once daily for 10 to 21 days [1].
• The exact duration of treatment depends on the individual's response and doctor's recommendation.

Benefits:

• By increasing platelet count, Oprelvekin can help reduce the risk of bleeding complications during chemotherapy [2].
• It may also decrease the need for platelet transfusions, which can be time-consuming and carry potential risks.

Important Considerations:

• Oprelvekin is not a cure for cancer and should be used as part of a comprehensive treatment plan.
• It can cause side effects like fever, fatigue, rash, bone pain, and headache [1].
• Oprelvekin is not suitable for everyone and may interact with other medications. It's crucial to talk to your doctor about your medical history and current medications before using Oprelvekin.